Predicting cisplatin tolerability in older adults with head and neck cancer – Insights for improved chemoradiation outcomes

Alexander Rühle; Nils H. Nicolay; M. Weymann; Sebastian Marschner; Harald Binder; Carmen Kut; Daniel R. Dickstein; Clemens Seidel; Alev Altay-Langguth; Erik Haehl; Alexander Fabian; Johannes Kraft; Sachin R. Jhawar; Peter Hambsch; Harry Quon; Arnulf Mayer; Claus Belka; Max Behrens; Sören Schnellhardt; Anca‐Ligia Grosu; Heinz Schmidberger; Carolin Senger; Goda Kalinauskaitė; Sujith Baliga; Panagiotis Balermpas; Dukagjin Blakaj; Marlen Haderlein; Thomas Kuhnt; Esmée L. Looman; Victor Lewitzki; Jens von der Grün; Constantinos Zamboglou; Jörg Andreas Müller; Justus Domschikowski; Eric Chen; Konstantinos Ferentinos; A.N. Elguindy; Benjamin P. Bakst; Marcelo Bonomi; Johannes Olbrich; Carmen Stromberger

doi:10.1016/j.radonc.2024.110697

Predicting cisplatin tolerability in older adults with head and neck cancer – Insights for improved chemoradiation outcomes

Alexander Rühle(University of Freiburg), Nils H. Nicolay(University Hospital Leipzig), M. Weymann(University of Freiburg), Sebastian Marschner(German Cancer Research Center), Harald Binder(Zimmer Biomet (Netherlands)), Carmen Kut(Johns Hopkins University), Daniel R. Dickstein(Icahn School of Medicine at Mount Sinai), Clemens Seidel(Leipzig University), Alev Altay-Langguth(Goethe University Frankfurt), Erik Haehl(German Cancer Research Center), Alexander Fabian(University Hospital Schleswig-Holstein), Johannes Kraft(University Hospital of Zurich), Sachin R. Jhawar(The Ohio State University Wexner Medical Center), Peter Hambsch(Leipzig University), Harry Quon(Johns Hopkins University), Arnulf Mayer(Johannes Gutenberg University Mainz), Claus Belka(LMU Klinikum), Max Behrens(University of Freiburg), Sören Schnellhardt(Friedrich-Alexander-Universität Erlangen-Nürnberg), Anca‐Ligia Grosu(University of Freiburg), Heinz Schmidberger(Johannes Gutenberg University Mainz), Carolin Senger(Freie Universität Berlin), Goda Kalinauskaitė(German Cancer Research Center), Sujith Baliga(The Ohio State University Wexner Medical Center), Panagiotis Balermpas(University of Zurich), Dukagjin Blakaj(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Marlen Haderlein(Universitätsklinikum Erlangen), Thomas Kuhnt(Leipzig University), Esmée L. Looman(University of Zurich), Victor Lewitzki(Universitätsklinikum Würzburg), Jens von der Grün(University of Zurich), Constantinos Zamboglou(University Hospitals of Cleveland), Jörg Andreas Müller(University Hospital in Halle), Justus Domschikowski(University Hospital Schleswig-Holstein), Eric Chen(École Polytechnique Fédérale de Lausanne), Konstantinos Ferentinos(European University Cyprus), A.N. Elguindy(The Ohio State University Wexner Medical Center), Benjamin P. Bakst(College of Mount Saint Vincent), Marcelo Bonomi, Johannes Olbrich(University Hospital Leipzig), Carmen Stromberger(Berlin Institute of Health at Charité - Universitätsmedizin Berlin)

Radiotherapy and Oncology

December 24, 2024

10.1016/j.radonc.2024.110697

Cited by 5

Related Papers

How mental health care should change as a consequence of the COVID-19 pandemic

|The Lancet Psychiatry|2020|1.9k

Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis

|JAMA Psychiatry|2018|796

Opioids for Chronic Noncancer Pain

|JAMA|2018|706

Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial

|The Lancet|2019|581

The Lancet Psychiatry Commission on youth mental health

|The Lancet Psychiatry|2024|580